Business Description
Cosmo Bio Co Ltd
ISIN : JP3298700000
Description
Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes purchase of reagents, instruments, clinical test drugs for research on life science and domestic sales.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 161.2 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-EBITDA | 0.04 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 4.27 | |||||
| Beneish M-Score | -2.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.5 | |||||
| 3-Year EBITDA Growth Rate | -11.7 | |||||
| 3-Year EPS without NRI Growth Rate | -9.6 | |||||
| 3-Year FCF Growth Rate | -4.3 | |||||
| 3-Year Book Growth Rate | 5.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 72.78 | |||||
| 9-Day RSI | 65.13 | |||||
| 14-Day RSI | 60.23 | |||||
| 3-1 Month Momentum % | -7.2 | |||||
| 6-1 Month Momentum % | -1.55 | |||||
| 12-1 Month Momentum % | 11.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.36 | |||||
| Quick Ratio | 6.28 | |||||
| Cash Ratio | 3.3 | |||||
| Days Inventory | 60.02 | |||||
| Days Sales Outstanding | 105.33 | |||||
| Days Payable | 34.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.47 | |||||
| Dividend Payout Ratio | 0.6 | |||||
| 3-Year Dividend Growth Rate | 18.6 | |||||
| Forward Dividend Yield % | 4.47 | |||||
| 5-Year Yield-on-Cost % | 12.74 | |||||
| 3-Year Average Share Buyback Ratio | 0.5 | |||||
| Shareholder Yield % | 4.47 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 33.15 | |||||
| Operating Margin % | 3.98 | |||||
| Net Margin % | 3.52 | |||||
| FCF Margin % | 6.6 | |||||
| ROE % | 3.9 | |||||
| ROA % | 3.04 | |||||
| ROIC % | 3.87 | |||||
| 3-Year ROIIC % | -10.17 | |||||
| ROC (Joel Greenblatt) % | 13.83 | |||||
| ROCE % | 4.87 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.28 | |||||
| PE Ratio without NRI | 22.26 | |||||
| Shiller PE Ratio | 15.84 | |||||
| PEG Ratio | 2.34 | |||||
| PS Ratio | 0.68 | |||||
| PB Ratio | 0.71 | |||||
| Price-to-Tangible-Book | 0.73 | |||||
| Price-to-Free-Cash-Flow | 10.25 | |||||
| Price-to-Operating-Cash-Flow | 8.86 | |||||
| EV-to-EBIT | 7.71 | |||||
| EV-to-EBITDA | 7.71 | |||||
| EV-to-Revenue | 0.39 | |||||
| EV-to-FCF | 5.95 | |||||
| Price-to-GF-Value | 1.05 | |||||
| Price-to-Projected-FCF | 0.57 | |||||
| Price-to-Median-PS-Value | 0.79 | |||||
| Price-to-Graham-Number | 0.85 | |||||
| Price-to-Net-Current-Asset-Value | 1.41 | |||||
| Price-to-Net-Cash | 9.63 | |||||
| Earnings Yield (Greenblatt) % | 12.97 | |||||
| FCF Yield % | 9.94 | |||||
| Forward Rate of Return (Yacktman) % | 17.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cosmo Bio Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 9,642 | ||
| EPS (TTM) (円) | 58.034 | ||
| Beta | -0.02 | ||
| 3-Year Sharpe Ratio | -0.09 | ||
| 3-Year Sortino Ratio | -0.12 | ||
| Volatility % | 10.94 | ||
| 14-Day RSI | 60.23 | ||
| 14-Day ATR (円) | 12.812566 | ||
| 20-Day SMA (円) | 1101.6 | ||
| 12-1 Month Momentum % | 11.31 | ||
| 52-Week Range (円) | 888 - 1229 | ||
| Shares Outstanding (Mil) | 5.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cosmo Bio Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cosmo Bio Co Ltd Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cosmo Bio Co Ltd Frequently Asked Questions
What is Cosmo Bio Co Ltd(TSE:3386)'s stock price today?
The current price of TSE:3386 is 円1119.00. The 52 week high of TSE:3386 is 円1229.00 and 52 week low is 円888.00.
When is next earnings date of Cosmo Bio Co Ltd(TSE:3386)?
The next earnings date of Cosmo Bio Co Ltd(TSE:3386) is .
Does Cosmo Bio Co Ltd(TSE:3386) pay dividends? If so, how much?
The Dividend Yield %  of Cosmo Bio Co Ltd(TSE:3386) is 4.47% (As of Today), Highest Dividend Payout Ratio of Cosmo Bio Co Ltd(TSE:3386) was 0.67. The lowest was 0.2. And the median was 0.39. The  Forward Dividend Yield % of Cosmo Bio Co Ltd(TSE:3386) is 4.47%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers